A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management

Published:2024-08-01 Issue:8 Volume:26 Page:556-565
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Warren Mark¹,Bergenstal Richard M.²^ORCID,Hager Matthew¹,Bashan Eran³,Hodish Israel⁴⁵^ORCID

Affiliation:

1. Endocrinology, Diabetes and Metabolism, Physicians East PA, Greenville, North Carolina, USA.

2. International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.

3. Hygieia, Inc., Livonia, Michigan, USA.

4. Hygieia PC., Livonia, Michigan, USA.

5. Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2024.0041

Reference22 articles.

1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

2. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

3. For debate; pharmacological priorities in advanced type 2 diabetes

4. Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018

5. Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP